维普期刊资源整合服务平台（V6.5）

73篇 您的检索式：作者名="HUGHES TP"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia显示文摘	Hughes TP Kaeda J Branford S		0，，15：	1
2	Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia显示文摘	Kaeda J Branford S	2003	N Engl J Med2003，349，15：	1
3	Meta-analysis of robot-assisted vs conventional laparoscopic and open pyeloplasty in children显示文摘	CUNDY TP HARLING L HUGHES~HALLETT A	2014	BJU Int2014，114，4：	1
4	Reduction of BCR-ABL transqript levels at 6, 12, and 18 months (too) cor- relates with long-term outcomes on imatinib (IM) at 72 Mo: an analysis from the international randomized study of interferon ver- sus STI571 (IRIS) in patients (pts) with chronic phase chronic myeloid leukemia (CML-CP) 显示文摘	HUGHES TP HOCHHAUS A BRANFORD S	2008	Blood2008，112，：	1
5	Chronic myelogenous leukemia显示文摘	Melo JV Hughes TP Apperley JF	2003	Hematology2003，，：	1
6	Impact of early dose intensity on cytogenetic and molecular responses in chronic-phase CML patients receiving 600 mg/day of imatinib as initial therapy显示文摘	Hughes TP Branford S White DL	2008	{H}Blood2008，，10：	1
7	ENESTnd up- date : continued superiority of nilotinib versus imatinib in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) 显示文摘	HUGHES TP HOCHHAUS A SAGLIO G	2010	Blood2010，116，：	1
8	The incidence of BCR-ABL mutations and their impact on outcome in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) treated with nilotinib or imatinib in ENESTnd: 36- month follow-up 显示文摘	HUGHES TP KIM D ETIENNE G	2011	Blood2011，118，：	1
9	Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia:an analysis from the International Randomized Study of Interferon and STI571(IRIS)显示文摘	Hughes TP Hochhaus A Branford S	2010	{H}Blood2010，，19：	1
10	Chronic Myeloid Leukemia 显示文摘	Melo JV Hughes TP Apperley JF	2003	Hematology Am Soc Hematol Educ Program2003，2003，1：	1
11	Chronic myeloid leukemia 显示文摘	Melo JV Hughes TP Apperley JF	2003	Hematol Am Soc Hematol Educ Program2003，，1：	1
12	Cardioprotective role of sodium thiosulfate on chronic heart failure by modulating endogenous H2S generation 显示文摘	Sen U Vacek TP Hughes WM	2008	Pharmacology2008，82，3：	1
13	A novel BCR-ABL transcript(e8a2)with the insertion of an inverted sequence of ABL intron 1bin a patient with Philadelphia-positive chronic myeloid leukaemia显示文摘	Branford S Rudzki Z Hughes TP	2000	Br J Haematol2000，109，：	1
14	Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia:an analysis from the international randomized study of interferon and STI571 (iris) 显示文摘	HUGHES TP HOCHHAUS A	2010	Blood2010，116，：	1
15	Moving treatment-free remission into mainstream clinical practice in CML 显示文摘	Hughes TP Ross DM	2016	Blood2016，24，：	1
16	Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase:correlations with acute graft-versus-host disease and relapse显示文摘	CROSS NC HUGHES TP FENG L	1993	Br J Haematol1993，84，1：	1
17	Nilotinib vs imatinibin patients with newly diagnosed Philadelphia chromosome-pos-itive chronic myeloid leukemia in chronic phase: ENESTnd3-year follow-up显示文摘	Larson RA Hochhaus A Hughes TP	2012	Leukemia2012，26，10：	1
18	Enhanced CHO cell-based transient gene expression with the epi-CHO expression system 显示文摘	Codamo J Munro TP Hughes BS	2011	Molecular Biotechnology2011，48，2：	1
19	Chronic myeloid leukemia 显示文摘	Melo JV Hughes TP Apperley JF	2003	Hematology2003，25，1：	1
20	Cardioprotective role of sodium thiosulfate on chronic heart failure by modulating endogenous H2S generation显示文摘	SEN U VACEK TP HUGHES WM	2008	Pharmacology2008，82，3：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示